Live Music in the Intensive Care Unit

NCT06442644 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 202

Last updated 2024-06-04

No results posted yet for this study

Summary

The goal of this quasi-experimental pre- post test study is to test a patient-tailored live music intervention's effect on stress and pain reduction in adult, critically ill patients admitted to the intensive care unit.

The main question it aims to answer is:

• Does live music reduce stress and pain in adult intensive care patients?

In the pre-post test design, the patients will be their own control. There will be no randomisation. Researchers will compare measurements of heartrate, respiration rate, heartrate variability, blood pressure and pain before and after the live music intervention to see if live music effects these vital parameters.

Participants will listen to live music in their room in the intensive care unit for 5 to 15 minutes.

Conditions

Interventions

OTHER

Live music in the intensive care unit

To test a patient-tailored live music intervention's effect on stress reduction in adult, critically ill patients admitted to the intensive care unit.

Sponsors & Collaborators

  • Region MidtJylland Denmark

    collaborator OTHER
  • Novo Nordisk A/S

    collaborator INDUSTRY
  • The Royal Conservatory of Music

    collaborator OTHER
  • Aarhus University Hospital

    lead OTHER

Principal Investigators

  • Linette Thorn, Master · Aarhus University Hospital

Study Design

Allocation
NA
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-09-30
Primary Completion
2025-12-31
Completion
2026-12-31

Countries

  • Denmark

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06442644 on ClinicalTrials.gov